SEVEN is a telehealth platform offering personalized GLP-1 medical weight loss programs — reviewed and prescribed by licensed clinicians, not algorithms. FDA-approved and individualized treatment options available.
Treatment eligibility is determined by a licensed clinician after reviewing your individual health intake. Joining early access does not guarantee treatment approval.
Persistent weight is rarely a willpower problem. It is a biology problem — and understanding that changes everything about how treatment should work.
Weight loss triggers hormonal shifts that increase hunger and reduce satiety — a biological feedback loop that works against sustained results. GLP-1 medications intervene at this level, not the behavioral one.
Food noise — the constant mental preoccupation with eating — is a neurobiological phenomenon, not a character flaw. Many patients on GLP-1 therapy describe its reduction as transformative to their daily experience. Learn more about food noise →
As weight decreases, metabolism adapts — burning fewer calories at rest. This is one reason weight loss plateaus occur even when patients maintain consistent effort. Medically supported programs are designed to account for this.
GLP-1 medications work through multiple biological pathways — not through stimulants, crash-inducing restriction, or willpower augmentation.
GLP-1 receptor agonists act on the brain's appetite centers to reduce hunger signals — making it physiologically easier to eat less without cognitive strain.
These medications slow gastric emptying — the rate at which food leaves the stomach — producing prolonged satiety after meals and reducing the drive to eat again quickly.
GLP-1 medications stimulate insulin release in response to elevated blood glucose and suppress glucagon — supporting more stable blood sugar levels throughout the day.
Many patients report a significant reduction in food-related intrusive thoughts — a shift that supports sustainable behavioral change beyond the pharmaceutical effect alone.
Our clinician-written resources explain how GLP-1 medications work in plain language — what the research shows, what patients actually experience, and what realistic outcomes look like.
Read: What Does GLP-1 Actually Do? →SEVEN's primary treatment pathway uses FDA-approved GLP-1 medications. In certain cases, a licensed provider may determine that a compounded medication is clinically appropriate and medically necessary based on your individual health history and circumstances.
Branded GLP-1 medications require a valid prescription from a licensed provider. SEVEN does not manufacture medications.
Compounded medications are not FDA-approved. All prescriptions require clinician review and are issued at the sole discretion of a licensed provider.
SEVEN is built around a clear process — from your first inquiry to ongoing clinical support.
Reserve your place and receive your free GLP-1 Starter Guide. You will be among the first notified when enrollment opens in your state.
At launch, complete a comprehensive online health intake covering your goals, medical history, and current health status. No office visit required.
A licensed clinician reviews your intake individually. If treatment is appropriate, your personalized protocol is coordinated through SEVEN and medication ships to your door. Ongoing clinical support is included.
Eligibility is always determined by a licensed clinician after reviewing your individual health intake. The following reflects general clinical guidelines, not a guarantee of eligibility.
General clinical guidelines support GLP-1 therapy for adults with a BMI of 30 or above without additional weight-related health conditions.
Adults with a BMI of 27 or higher and at least one condition such as high blood pressure, type 2 diabetes, or high cholesterol may also qualify.
SEVEN's programs are designed for adults. Eligibility requirements may vary by state and treatment type.
GLP-1 medications are not appropriate for patients with certain conditions including personal or family history of medullary thyroid carcinoma or MEN2. Your clinician will review your full history.
Treatment eligibility is determined exclusively by a licensed clinician based on your individual medical history and clinical criteria. Joining early access or completing an intake does not guarantee treatment approval. GLP-1 medications are not appropriate for everyone.
A plain-language explanation of how GLP-1 medications regulate hunger, reduce food noise, and support sustainable weight management.
Read article →The persistent mental preoccupation with food that makes dieting cognitively exhausting — and what actually helps.
Read article →The biology behind late-night hunger and why willpower consistently fails in the evening.
Read article →